Digital Health Solutions Is The Fastest Growing Segment Fueling The Growth Of Smart Inhalers Market

Smart Inhalers Market
Smart Inhalers Market 


The global Smart Inhalers Market is estimated to be valued at US$ 374.0 Mn in 2023 and is expected to exhibit a CAGR of 58.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Smart inhalers incorporate digital monitoring technologies that help patients better manage their respiratory conditions. These connected inhalers have sensors that can track medication use and send data to a companion smartphone app. This allows patients and physicians to monitor symptoms and medication adherence in real-time.

Market key trends:
One of the major trends in the smart inhalers market is the rising development of combination inhalers integrated with Bluetooth connectivity. Combination inhalers containing two or more active drugs are gaining traction as they help treat comorbid respiratory conditions with a single inhaler. Major players are focusing on developing such combination inhalers integrated with Bluetooth technology that can automatically send usage data to a connected smartphone. This allows monitoring treatment patterns and helps physicians modify therapy for better management of respiratory diseases.
Segment Analysis
Smart inhalers market is segmented into smart dry powder inhalers, smart metered dose inhalers and smart nebulizers. Among these, the smart metered dose inhalers segment dominated the market in 2022 and accounted for the largest market share. This is attributed to wider usage of metered dose inhalers for treatment of asthma and COPD. The smart metered dose inhalers aids patients to monitor medication use and adherence to prescribed treatment plans, thereby driving the growth of this segment.

Key Takeaways
The global Smart Inhalers Market Growth is expected to witness high growth, exhibiting 58% CAGR over the forecast period, due to increasing prevalence of chronic respiratory diseases like asthma and COPD.

Regional analysis
North America dominated the smart inhalers market and accounted for largest market share in 2023 owing to rising awareness regarding smart inhalers and presence of well-established healthcare infrastructure and key market players in the region. Asia Pacific is expected to witness fastest growth over the forecast period led by increasing healthcare spending and rising prevalence of chronic respiratory diseases.

Key players
Key players operating in the smart inhalers market are Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed, among others. GSK and Novartis have strong presence and hold significant share of the overall market.

For more details on the report,  Read- https://www.newsstatix.com/luxury-travel-market-trends-size-and-share-analysis/

For more insights, read- https://www.ukwebwire.com/smart-inhalers-market-trends-size-and-share-analysis/

Post a Comment

0 Comments